MD Anderson Receives $20M from Ross Perot for Work on Personalized Cancer Therapies
August 27, 2010
MD Anderson Receives $20M from Ross Perot for Work on Personalized Cancer Therapies
The donation will fund research at the Institute for Personalized Cancer Therapy and the Center for Targeted Therapy into more effective drug treatments, including investigations into protein pathway-directed therapies, said an official.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Evotec to Use PhosphoScout Platform in Oncology Biomarker Alliance with Roche
July 1, 2011 / ProteoMonitor - Phosphoproteomic Screens Elucidate Feedback Loop Linked to mTOR Inhibitor Resistance
June 17, 2011 / ProteoMonitor - Researchers ID Gastric Cancer Biomarker Aimed for Use in DTC Tests in US, China
May 6, 2011 / ProteoMonitor - Magnetic Biosensor Could Enable Simultaneous Monitoring of Thousands of Protein-Ligand Bindings
May 6, 2011 / ProteoMonitor - NCI's Early Detection Research Network Running Trials to Compare Biomarker-Based Cancer Diagnostics
April 22, 2011 / ProteoMonitor